GWM
LMAT icon

Gilpin Wealth Management’s LeMaitre Vascular LMAT Stock Holding History

Gilpin Wealth Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$166 Sell
2
-1
-33% -$89 ﹤0.01% 1183
2026
Q2 		$288 Sell
3
-1
-25% -$103 ﹤0.01% 836
2026
Q1 		$437 Buy
4
+2
+100% +$191 ﹤0.01% 656
2025
Q4 		$163 Buy
+2
New +$172 ﹤0.01% 714

Other funds holding LMAT

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RWS
Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Gilpin Wealth Management's LMAT Position: Q3 2026 in Review

Gilpin Wealth Management reduced its LeMaitre Vascular (LMAT) stake by 33% in Q3 2026, selling an estimated $89 and leaving 2 shares worth $166. The position accounts for ﹤0.01% of the portfolio, ranked #1183.

Gilpin Wealth Management first reported a position in LMAT in Q4 2025 and has held it in 4 quarters since. The position peaked at $437 in Q1 2026. 7 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Gilpin Wealth Management held 2 shares of LeMaitre Vascular worth $166 as of Q3 2026.
  • Gilpin Wealth Management sold 1 LeMaitre Vascular share in Q3 2026, an estimated $89.
  • LeMaitre Vascular made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1183 holding.
  • Gilpin Wealth Management first reported a position in LeMaitre Vascular in Q4 2025 and has held it in 4 quarters since.
  • Gilpin Wealth Management's LeMaitre Vascular position peaked at $437 in Q1 2026.
  • 7 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.